https://pubmed.ncbi.nlm.nih.gov/35834137/?dopt=Abstract
Unraveling the therapeutic potential of GANT61/Dactolisib combination as a novel prostate cancer...
Aberrant activation of several signaling pathways has been implicated in prostate cancer (PCa) progression to castrate-resistant prostate cancer (CRPC)....